Cargando…
Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women
British Journal of Cancer (2002) 87, 1480–1480. doi:10.1038/sj.bjc.6600652 www.bjcancer.com © 2002 Cancer Research UK Correction to: British Journal of Cancer 2001; 85 (Suppl 2): 1–5. doi:10.1054/bjoc.2001.1981
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376299/ http://dx.doi.org/10.1038/sj.bjc.6600652 |
| _version_ | 1782154720576536576 |
|---|---|
| author | Jonat, W |
| author_facet | Jonat, W |
| author_sort | Jonat, W |
| collection | PubMed |
| description | British Journal of Cancer (2002) 87, 1480–1480. doi:10.1038/sj.bjc.6600652 www.bjcancer.com © 2002 Cancer Research UK Correction to: British Journal of Cancer 2001; 85 (Suppl 2): 1–5. doi:10.1054/bjoc.2001.1981 |
| format | Text |
| id | pubmed-2376299 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2002 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23762992009-09-10 Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women Jonat, W Br J Cancer Erratum British Journal of Cancer (2002) 87, 1480–1480. doi:10.1038/sj.bjc.6600652 www.bjcancer.com © 2002 Cancer Research UK Correction to: British Journal of Cancer 2001; 85 (Suppl 2): 1–5. doi:10.1054/bjoc.2001.1981 Nature Publishing Group 2002-12-02 2002-12-02 /pmc/articles/PMC2376299/ http://dx.doi.org/10.1038/sj.bjc.6600652 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Erratum Jonat, W Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women |
| title | Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women |
| title_full | Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women |
| title_fullStr | Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women |
| title_full_unstemmed | Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women |
| title_short | Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women |
| title_sort | goserelin (zoladex™) – its role in early breast cancer in pre- and perimenopausal women |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376299/ http://dx.doi.org/10.1038/sj.bjc.6600652 |
| work_keys_str_mv | AT jonatw goserelinzoladexitsroleinearlybreastcancerinpreandperimenopausalwomen |